Frequently asked questions
The market for Irritable Bowel Syndrome with Constipation Drugs is expected to reach US$ 2.23 Bn in 2026.
The Irritable Bowel Syndrome with Constipation Drugs market is expected to see significant CAGR growth over the coming years, at 6.2%.
The report is forecasted from 2022-2029
The base year of this report is 2021.
Abbott Laboratories, Inc., Ardelyx. Inc., Astellas Pharma Inc., AstraZeneca Plc., Bayer AG, Fresenius Kabi AG, Ironwood Pharmaceuticals, Inc., Sanofi, SK Biopharmaceuticals Co., Ltd., Sucampo AG, Synergy Pharmaceuticals, Inc., and Synthetic Biologics, Inc. are some of the major players in the global market.